His primary areas of investigation include Radiation therapy, Internal medicine, Surgery, Oncology and Head and neck cancer. His Radiation therapy research integrates issues from Cancer, Survival rate, Carcinoma, Hazard ratio and Concomitant. His studies in Internal medicine integrate themes in fields like Endocrinology and Immediate early protein.
As a member of one scientific family, Jean Bourhis mostly works in the field of Surgery, focusing on Epidermoid carcinoma and, on occasion, Cetuximab. His Oncology study deals with Fluorouracil intersecting with Docetaxel, Performance status and Taxane. His Head and neck cancer research includes elements of Odds ratio, Combined Modality Therapy, Nuclear medicine and MEDLINE.
His scientific interests lie mostly in Internal medicine, Radiation therapy, Oncology, Head and neck cancer and Surgery. His Internal medicine study frequently links to adjacent areas such as Gastroenterology. The Radiation therapy study which covers Cancer that intersects with Cancer research.
His biological study spans a wide range of topics, including Dose fractionation, Cetuximab and Fluorouracil. Head and neck cancer connects with themes related to Meta-analysis in his study. In most of his Surgery studies, his work intersects topics such as Epidermoid carcinoma.
The scientist’s investigation covers issues in Internal medicine, Radiation therapy, Oncology, Transplantation and Radiology. His Radiation therapy research incorporates elements of Cancer and Immunotherapy. He has included themes like Cancer research, Clinical trial and Immune system in his Cancer study.
His Oncology study combines topics from a wide range of disciplines, such as Chemotherapy, Myeloid, Randomized controlled trial, Retrospective cohort study and Stem cell. His research in Transplantation intersects with topics in Gastroenterology and Incidence, Cumulative incidence. The various areas that Jean Bourhis examines in his Head and neck cancer study include Concomitant and Intensive care medicine.
His scientific interests lie mostly in Internal medicine, Radiation therapy, Oncology, Randomized controlled trial and Myeloid leukemia. His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology. As part of his studies on Radiation therapy, he often connects relevant subjects like Cancer.
His study in Oncology is interdisciplinary in nature, drawing from both Standard of care and Neuroprotection. His Randomized controlled trial research includes themes of Cetuximab, Head and neck cancer, Carboplatin, Chemoradiotherapy and Subgroup analysis. His studies deal with areas such as Meta-analysis, Concomitant, Curative surgery and Chemotherapy as well as Head and neck cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon;Aurélie le Maître;Emilie Maillard;Jean Bourhis.
Radiotherapy and Oncology (2009)
Postoperative Irradiation With or Without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
Jacques Bernier;Christian Domenge;Mahmut Ozsahin;Katarzyna Matuszewska.
The New England Journal of Medicine (2004)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Lionel Apetoh;François Ghiringhelli;Antoine Tesniere;Antoine Tesniere;Antoine Tesniere;Michel Obeid;Michel Obeid;Michel Obeid.
Nature Medicine (2007)
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Jacques Bernier;Jay S. Cooper;T. F. Pajak;M. Van Glabbeke.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck (2005)
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang.
The Lancet (2006)
Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients
Bertrand Baujat;Hélène Audry;Jean Bourhis;Anthony Tak-cheung Chan.
International Journal of Radiation Oncology Biology Physics (2006)
Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
José Baselga;José M. Trigo;Jean Bourhis;Jacques Tortochaux.
Journal of Clinical Oncology (2005)
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
Lester J. Peters;Brian O'Sullivan;Jordi Giralt;Thomas J. Fitzgerald.
Journal of Clinical Oncology (2010)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site
Pierre Blanchard;Bertrand Baujat;Victoria Holostenco;Abderrahmane Bourredjem.
Radiotherapy and Oncology (2011)
Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle
Didier Blaise;Mathieu Kuentz;Cecile Fortanier;Jean Henri Bourhis.
Journal of Clinical Oncology (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: